commercial-phases_LBB_phase-6_growth_color_800x800
Phase 6

Growth

We help you turn early traction into market leadership. Sustained growth depends on expanding evidence, coverage, and clinical support as competitors and the market respond.

Phase overview

Growth is the phase where you move beyond initial market entry and focus on sustained adoption, market expansion, and competitive differentiation. Your device has commercial traction, but building market leadership requires ongoing work: disseminating clinical evidence, expanding payer coverage, developing the portfolio, and engaging clinical advocates. This is also where the commercial strategy established at Foundation is tested against real market conditions and either reinforced or revised. Growth can include international expansion, new indications, and portfolio extension as your company matures.


What happens in this phase

Each phase draws on a different combination of our disciplines and sub-disciplines. These are the ones that sustain adoption and build a defensible market position.

Evidence Planning

Real-world evidence generated and applied to support adoption and coverage decisions.

Reimbursement

Payer coverage expanded across plans, regions, and sites of care.

Medical Affairs

KOL relationships sustained and expanded with advocates, investigators, and community clinicians.

Product Strategy

Portfolio strategy and new indications prioritized by commercial potential.

Market & Investor Strategy

Partnerships, market expansion, and exit readiness that build long-term value.

Marketing Programs

Ongoing programs optimized against performance metrics to drive sustained adoption.


AdobeStock_134638823_Color_800x800
What you walk away with

You leave Growth with real-world evidence that supports adoption and coverage, broader payer coverage, and an expanded network of clinical advocates. Your portfolio and new indications are prioritized by commercial potential. Your partnership and exit strategy builds long-term value, and your programs are guided by performance metrics that show what drives adoption.


Why this phase matters

Many devices are built for launch and then left to coast. Competitors respond, clinical opinion shifts, and coverage decisions change, and positioning that worked with early adopters often fails with mainstream buyers. Continued investment in evidence, access, and clinical support is what separates a niche device from a category leader.


commercial-phases_LBB_hero_color_800x800
BACK TO

Commercial Phases

Return to the full commercialization journey to see where we can support your next stage.

Content Card - Just Mighty - Launch - Two Color - Full (1920 x 1080)
Logo - Just Mighty - White Logo (400 x 400)

Your innovation Just Might change the world. But is your strategy up to the task? We help you turn Just Might into Just Mighty.